-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tislelizumab in Muscle Invasive Bladder Cancer (MIBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tislelizumab in Muscle Invasive Bladder Cancer (MIBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tislelizumab in Muscle Invasive Bladder Cancer (MIBC) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tislelizumab in Urethral Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tislelizumab in Urethral Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tislelizumab in Urethral Cancer Drug Details: Tislelizumab (Baizean, Tevimbra, Tizveni) is...
-
Product Insights
NewOsteoporosis – Drugs In Development, 2024
Empower your strategies with our Osteoporosis – Drugs In Development, 2024 report and make more profitable business decisions. Osteoporosis, or thinning bones, makes bones weak and more likely to break. Risk factors for osteoporosis include aging, being female, low body weight, low sex hormones or menopause, smoking, and some medications. Signs and symptoms include back pain, caused by a fractured or collapsed vertebra, loss of height over time, a stooped posture, and a bone fracture that occurs much more easily than...
-
Product Insights
NewPlasma Cell Neoplasm – Drugs In Development, 2024
Empower your strategies with our Plasma Cell Neoplasm – Drugs In Development, 2024 report and make more profitable business decisions. Plasma Cell Neoplasm or plasma cell cancer is a group of diseases involving B-cells. These tumors are found in soft tissues that can be malignant or benign. Multiple Myeloma, lymphoplasmacytic lymphoma, plasmacytoma are the types of plasma cell cancers. Of all three multiple Myeloma is the most common and aggressive form. Age, chronic infection, exposure to radiation, hereditary factors, are some...
-
Product Insights
Hematological Disorders Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Hematological Disorders Pipeline Market Report Overview The hematological disorders pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segments · Hemostasis Tests · Coagulation Analyzers · Special Coagulation Tests · Hematology Tests · General Coagulation Tests Key...
-
Product Insights
Auto-Immune Diseases Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Auto-immune diseases Pipeline Market Report Overview Auto-immune diseases are used for detection of autoimmune disorder by identifying auto-antibodies in the patient’s test sample. The auto-immune diseases pipeline market research report provides a comprehensive understanding of the pipeline products and their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Territories · The...
-
Product Insights
MRI Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
MRI Systems Pipeline Market Report Overview Magnetic Resonance Imaging (MRI) generates clear and detailed images of internal organs and tissues using radiofrequency and a strong magnetic field. MRI is generally preferred for the diagnosis of brain and other neurological disorders. The 3T, 1.5T and 0.2-1.2T MRI systems have been tracked under this category. The MRI Systems pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HH-2853 in Natural Killer Cell Lymphomas
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HH-2853 in Natural Killer Cell Lymphomas report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HH-2853 in Natural Killer Cell Lymphomas Drug Details: HH-2853...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tucidinostat in Hepatocellular Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tucidinostat in Hepatocellular Carcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tucidinostat in Hepatocellular Carcinoma Drug Details: Tucidinostat (Epidaza, Hiyasta) is a...